Selumetinib plus dacarbazine versus placebo plus...

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study

Robert, Caroline, Dummer, Reinhard, Gutzmer, Ralf, Lorigan, Paul, Kim, Kevin B, Nyakas, Marta, Arance, Ana, Liszkay, Gabriella, Schadendorf, Dirk, Cantarini, Mireille, Spencer, Stuart, Middleton, Mark
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70237-7
Date:
July, 2013
File:
PDF, 227 KB
english, 2013
Conversion to is in progress
Conversion to is failed